Interní Med. 2012; 14(2): 73-77

Depression and cardiovascular diseases

MUDr.Eva Kitzlerová, Ph.D.
Psychiatrická klinika 1. LF UK a VFN, Praha

Depressive disorder and cardiovascular diseases have the common pathophysiological mechanisms. They include both biological and

behavioral mechanisms. The principal are three biological ones: the activation of hypothalamo-pitutio-adrenal axis with increased

activation of sympathetic nervous system, the decreased vagal tonus followed by decreased heart rate variability and changes in thrombogenesis

with increased thrombocytic agregability. These three mechanisms are followed by the cascade of another processes, which

are interconnected with each other, they are mutually inseparable and cause the damage of cardiovascular system. These findings are

important for clinical praxis. Patients who suffer nontreated depressive disorder have the higher risk of development of the cardiovascular

diseases than the depressive patients treated with antidepressants including the tricyclic ones, which have the potentially risk of

cardiotoxicity. Hopeful is using the SSRI antidepressants which have the benign cardiovascular profile.

Keywords: depression, cardiovascular diseases, pathophysiological mechanisms, treatment

Published: February 22, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kitzlerová E. Depression and cardiovascular diseases. Interní Med. 2012;14(2):73-77.
Download citation

References

  1. Ward HE, Tueth M, Sheps D. Depression and cardiovascular disease. Curr Opin Psychiatry 2003; 16: 221-225. Go to original source...
  2. Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001; 58: 221-227. Go to original source... Go to PubMed...
  3. Lesperance F, Frasure-Smith N. Depression in patients with cardiac disease: A practical review. J Psychosom Res 2000; 48: 379-391. Go to original source... Go to PubMed...
  4. Grunau GL, Ratner PA, Goldner EM, Sheps S. Is early- and late-onset depression after acute myocardial infarction associated with long-term survival in older adults? A populationbased study. Can J Cardiol 2006; 22: 473-478. Go to original source... Go to PubMed...
  5. Kitzlerová E. Patofyziologické souvislosti kardiovaskulárních onemocnění a depresivní poruchy a trendy v jejich léčbě. Psychiatrie 2007; 1: 31-38.
  6. Kitzlerová E, Anders M. The role of some new factors in the pathophysiology of depression and cardiovascular disease: Overview of Recent Research. Neuroendocrinol Lett 2007; 28(6): 832-840. Go to PubMed...
  7. Malhotra S, Tesar GE, Franco K. The Relationship between Depression and Cardiovascular Disorders. Current Psychiatry Reports 2000; 2: 241-246. Go to original source... Go to PubMed...
  8. Vacarino V. The association between depression and coronary heart disease incidence. Drugs of Today 2000; 36(10): 715-724. Go to original source... Go to PubMed...
  9. Glassman AH, O'Connor CM, Califf RM, et al. for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-709. Go to original source... Go to PubMed...
  10. Taylor CB, Youngblood ME, Catellier D, et al. for the ENRICHD Investigators. Effects of Antidepressant Medication on Morbidity and Mortality in Depressed Patients After Myocardial Infarction. Arch Gen Psychiatry 2005; 62: 792-798. Go to original source... Go to PubMed...
  11. Honig A, Maes M. Psychoimmunology as a common pathogenetic pathway in myocardial infarction, depression and cardiac death. Curr Opin Psychiatry 2000; 13: 661-664. Go to original source...
  12. Švestka J. Antidepresiva a QT interval. Psychiatrie pro praxi 2001; 2: 84.
  13. Slavíček J, Paclt I, Hamplová J, et al. Antidepressant Drugs and Heart Electric Field. Physiological Research 1998; 47: 297-300. Go to PubMed...
  14. Sauer WH, Berlin JA, Kimmel SE. SSRIs and myocardial infarction. Circulation 2001; 104: 1894-1898. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.